Kantoku Nagakawa

Papers

Total Citations

H-Index

About

Kantoku Nagakawa is a pioneering pancreatic surgeon whose work centers on advancing minimally invasive techniques for complex pancreatic diseases. His research focuses on the safety and feasibility of repeated minimally invasive pancreatectomy, particularly for patients with intraductal papillary mucinous neoplasm (IPMN) in the remnant pancreas—a challenging scenario where preserving quality of life is paramount. Nagakawa’s landmark 2024 case report, though early in citation impact, demonstrates the potential of robotic and laparoscopic approaches to reduce morbidity, blood loss, and hospital stays even in reoperative settings. This work builds on his broader contributions to refining surgical strategies for pancreatic tumors, emphasizing patient-centered outcomes and technical innovation. While his citation count is still growing, Nagakawa’s dedication to pushing the boundaries of minimally invasive surgery positions him as an emerging leader in pancreatic oncology. His efforts are particularly notable for addressing the unmet need of safe, repeat resections in patients with recurrent disease, offering hope for improved long-term management. For students and researchers, Nagakawa’s work exemplifies how meticulous surgical technique and thoughtful case selection can expand the horizons of what is possible in pancreatic surgery.